Red Biotechnology Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Chronic Diseases And Rise In R&D Investments


Red Biotechnology Market


Red biotechnology refers to the application of biotechnology in human and animal healthcare. It involves production of therapeutics, diagnostics, regenerative medicines, biomaterials, medical devices, and other products used for treatment or prevention of diseases in humans or animals. Red biotechnology utilizes cell and tissue culture, bioinformatics, molecular tagging, DNA sequencing and genetic engineering to develop diagnostics tests, therapeutics, monoclonal antibodies, recombinant proteins, blood and vaccines.


Market Dynamics:
Red biotechnology market is primarily driven by increasing prevalence of chronic diseases globally. According to World Health Organization (WHO), chronic diseases accounted for approximately 70% of all deaths worldwide in 2020, equivalent to 41 million deaths annually. Cancer, cardiovascular diseases, diabetes, chronic respiratory diseases, and other noncommunicable diseases collectively are responsible for huge healthcare costs and reduced productivity. Rising geriatric population susceptible to age-related conditions also contributes to the market growth. According to UN estimates, the population aged 65 years and above is projected to grow from 703 million in 2019 to 1.5 billion in 2050.

Another key driver is increasing R&D investments in development of novel biologics and biosimilars. Biopharmaceutical companies are investing heavily in research of targeted therapies, antibody drug conjugates, cell and gene therapies to develop advanced treatment options. For instance, Amgen invested over US$ 4.5 billion in R&D in 2021 focusing on oncology, inflammation, cardiovascular,
Segment Analysis

The red biotechnology market is dominated by biopharmaceuticals segment. Biopharmaceuticals include therapeutic drugs and vaccines that are manufactured using biological sources like microbes, plants, animals and genetic engineering. This segment holds the largest share owing to increasing prevalence of chronic diseases and growing demand for advanced biologics and monoclonal antibody drugs for treating cancer, diabetes, cardiovascular diseases and other indications.

PEST Analysis

Political: Government regulations and funding for research promote growth of red biotechnology. Economic: Rising healthcare spending and increasing demand for low-cost biologics drive market growth. Social: Growing awareness about benefits of biologics and stem cell therapies fuel adoption. Technological: Advancements in genetic engineering, protein therapeutics and development of biosimilars support market expansion.

Key Takeaways

Global Red Biotechnology Market Demand is expected to grow from US$ 742.80 billion in 2023 to US$ 1.3 trillion by 2030, exhibiting a CAGR of 10.7% over the forecast period. The biopharmaceuticals segment dominates owing to high demand for therapeutic drugs and monoclonal antibodies. Regionally, North America holds the largest share due to presence of major players and technological advancements. However, Asia Pacific is emerging as the fastest growing market due to increasing R&D spending and strengthening healthcare infrastructure.

Key players operating in the red biotechnology market are Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, Astellas Pharma. These players are focusing on developing innovative therapies and biosimilars through collaborations and acquisitions. 

Comments

Post a Comment

Popular posts from this blog

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi
Read more

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man
Read more